Avinger Inc (NASDAQ:AVGR) is performing outstandingly well today on news of …
Cara's shares are responding positively to the news that the biotech signed an ex-U.S. licensing deal with Vifor Fresenius Medical Care Renal Pharma Ltd ... This …
Short seller Andrew Left, founder of Citron Research, was up to his old tricks on Thursday, singling out medical-technology company Inogen as overvalued. The combination of his report and its accompanying tweet sent Inogen's stock tumbling …
Maintaining its streak of positive earnings surprises, Varian Medical Systems …
CVS stock at a glance. Despite languishing at $62 per share in ... "At The Future of Healthcare conference in Las Vegas, we saw Dr. [Troy] Brennan, chief medical …
And this doesn’t take into account the medical device market for contacts or …
Polling shows 76 percent of Californians across the political and demographic …
Currently, Global Blood Therapeutics is a Zacks Rank #3 (Hold) in the Medical - Biomedical and Genetics industry ... At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected. …
Nuance is a publicly traded company listed on the NASDAQ stock exchange. The SEC filing states Nuance discovered in December 2017 someone not authorized to do so gained access to 45,000 patient reports hosted on one of Nuance's …
According to Marcus, medical research philanthropy is north of $33 billion ... A strong economy and a willing stock market are fueling increases in venture …